» Articles » PMID: 34779545

The Spatial Distribution of Immune Cell Subpopulations in Hepatocellular Carcinoma

Overview
Journal Cancer Sci
Specialty Oncology
Date 2021 Nov 15
PMID 34779545
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Infiltrating immune cells in the tumor microenvironment (TME) influence tumor progression and patient prognosis, making them attractive therapeutic targets for immunotherapy research. A deeper understanding of immune cell distributions in the TME in hepatocellular carcinoma (HCC) is needed to identify interactions among different immune cell types that might impact the effectiveness of potential immunotherapies. We performed multiplex immunohistochemistry using a tissue microarray of samples from 302 patients with HCC to elucidate the spatial distributions of immune cell subpopulations (CD3 , CD4 , CD8 , CD66b , and CD68 ) in HCC and normal liver tissues. We analyzed the associations between different immune subpopulations using Pearson's correlation. G(r) functions, K(r) functions and Euclidean distance were applied to characterize the bivariate distribution patterns among the immune cell types. Cox regression and Kaplan-Meier analysis were used to evaluate the associations between tumor infiltration by different immune cells and patient outcomes after curative surgery. We also analyzed the relationship between the spatial distribution of different immune cell subpopulations with HCC patient prognosis. We found that the immune cell spatial distribution in the HCC TME is heterogeneous. Our study provides a theoretical basis for HCC immunotherapy.

Citing Articles

The Prognostic Value of Peripheral Blood Inflammatory Markers in Hepatocellular Carcinoma Treated with Lenvatinib Combined with PD-1 Inhibitors.

Xin Y, Liu N, Peng G, Huang X, Cao X, Zhou X J Hepatocell Carcinoma. 2025; 12:135-147.

PMID: 39877858 PMC: 11774115. DOI: 10.2147/JHC.S486910.


Multiplex immunohistochemistry to explore the tumor immune microenvironment in HCC patients with different GPC3 expression.

Zhou M, Zhou Z, Hu L, Chen S, Meng F, Chen J J Transl Med. 2025; 23(1):88.

PMID: 39838375 PMC: 11748271. DOI: 10.1186/s12967-025-06106-0.


Characterizing cell-type spatial relationships across length scales in spatially resolved omics data.

Dos Santos Peixoto R, Miller B, Brusko M, Aihara G, Atta L, Anant M Nat Commun. 2025; 16(1):350.

PMID: 39753600 PMC: 11699133. DOI: 10.1038/s41467-024-55700-1.


Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma.

Zhang J, Liu S, Wu M, Shi W, Cai Y Diagn Pathol. 2024; 19(1):150.

PMID: 39578844 PMC: 11583552. DOI: 10.1186/s13000-024-01582-2.


Characterizing cell-type spatial relationships across length scales in spatially resolved omics data.

Dos Santos Peixoto R, Miller B, Brusko M, Aihara G, Atta L, Anant M bioRxiv. 2024; .

PMID: 39314450 PMC: 11418938. DOI: 10.1101/2023.10.05.560733.


References
1.
de Martel C, Maucort-Boulch D, Plummer M, Franceschi S . World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma. Hepatology. 2015; 62(4):1190-200. PMC: 5019261. DOI: 10.1002/hep.27969. View

2.
Zhou S, Yin D, Hu Z, Luo C, Zhou Z, Xin H . A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression. Hepatology. 2019; 70(4):1214-1230. DOI: 10.1002/hep.30630. View

3.
Zhou Z, Wang P, Sun R, Li J, Hu Z, Xin H . Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J Immunother Cancer. 2021; 9(3). PMC: 7949476. DOI: 10.1136/jitc-2020-001946. View

4.
Quail D, Joyce J . Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013; 19(11):1423-37. PMC: 3954707. DOI: 10.1038/nm.3394. View

5.
Siegel R, Miller K, Jemal A . Cancer statistics, 2018. CA Cancer J Clin. 2018; 68(1):7-30. DOI: 10.3322/caac.21442. View